Connect Biopharma Holdings Ltd (CNTB) — Long-term Investment Intensity
Connect Biopharma Holdings Ltd (CNTB) has a Long-term Investment Intensity of 5.4% as of December 2022. Long-term investments of $65.74 Million represent 5.4% of total assets of $1.21 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Connect Biopharma Holdings Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Connect Biopharma Holdings Ltd Long-term Investment Intensity (2022–2022)
This chart shows how Connect Biopharma Holdings Ltd's Long-term Investment Intensity has evolved across 1 annual periods from 2022 to 2022. As of December 2022, the intensity stands at 5.4%, reflecting long-term investments of $65.74 Million against total assets of $1.21 Billion USD. Explore CNTB debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Connect Biopharma Holdings Ltd (2022–2022)
The table below presents the year-by-year Long-term Investment Intensity for Connect Biopharma Holdings Ltd from 2022 to 2022, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see CNTB market cap overview.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2022 | 37.8% | $65.74 Million | $174.01 Million | — |